Firm raided over workers' bile duct cancer

OSAKA, Japan - Investigators from the Osaka Labor Bureau of the Ministry of Health, Labor and Welfare enter printing firm Sanyo-CYP Co. in Osaka on April 2, 2013, to search the office on suspicion the company neglected its duty to take proper care of its workers' health. Seventeen of them suffered from bile duct cancer, eight of whom died.

Sample
PDF Preview

Product Code
ILEA001180889

Registered date
2013/4/02 00:00:00

Credit
Kyodo / Kyodo News Images

Media source
2013 Kyodo News

Media size
2978 × 2232 pixel

Resolution
240 dpi

Deployment size
889.62(KB)*

Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos

Man who traveled from W. Africa tests negative for Ebola

TOKYO, Japan - Photo taken Oct. 28, 2014, shows the National Center for Global Health and Medicine in Tokyo's Shinjuku Ward, to which a man, who traveled from West Africa and showed elevated body temperature upon arrival at Tokyo's Haneda airport, was admitted the previous day. The Canadian journalist tested negative for the Ebola virus but will remain hospitalized and under observation for a few more days, according to the Ministry of Health, Labor and Welfare.

Novartis division head Epstein

TOKYO, Japan - David Epstein (L), division head at Novartis AG, the Swiss-based pharmaceutical giant, holds talks with Japanese Health, Labor and Welfare Minister Norihisa Tamura (R) at the ministry in Tokyo on Sept. 26, 2013. Tamura summoned Epstein and sharply criticized the firm for triggering a scandal involving Novartis Pharma K.K., the Japanese subsidiary of Novartis AG. The unit allegedly engaged in deceptive advertizing for the blood pressure-lowering drug Diovan by citing a study based on manipulated clinical data.

MRI headquarters in Las Vegas

LAS VEGAS, United States - Photo taken April 26, 2013, shows the headquarters in Las Vegas of asset management firm MRI International Inc. Japan's Securities and Exchange Surveillance Commission raided the Tokyo office of MRI that day as the company is suspected of mishandling funds invested by thousands of Japanese clients.

MRI International

TOKYO, Japan - Photo shows the building housing MRI International Inc.'s Japan office in Tokyo on April 26, 2013. The U.S. asset management firm is suspected of mishandling funds invested by thousands of Japanese clients, resulting in losses totaling more than 130 billion yen, sources familiar with the matter said April 26. The Securities and Exchange Surveillance Commission raided the Tokyo office of the Nevada-based company and other related locations that afternoon.

Firm raided over workers' bile duct cancer

OSAKA, Japan - Investigators from the Osaka Labor Bureau of the Ministry of Health, Labor and Welfare leave printing firm Sanyo-CYP Co. in Osaka on April 2, 2013, after confiscating documents during a search on suspicion that the company neglected its duty to take proper care of its workers' health. Seventeen workers suffered from bile duct cancer, eight of whom have died.

Mitsubishi Tanabe Pharma ordered to suspend some operations

TOKYO, Japan - Mitsubishi Tanabe Pharma Corp. President Michihiro Tsuchiya (L) and Takehiko Fujii (C), president of subsidiary Bipha Corp., apologize in Tokyo on April 13, 2010, after the Health, Labor and Welfare Ministry ordered Mitsubishi Tanabe Pharma to suspend some of its pharmaceutical manufacturing and sales operations for 25 days over the alleged falsification of blood product test data. The subsidiary, which manufactured the product and falsified the data, was ordered to suspend its drug manufacturing business for 30 days.

Japan declares outbreak of new flu after WHO action

TOKYO, Japan - Japanese health minister Yoichi Masuzoe speaks at a press conference at the Ministry of Health, Labor and Welfare on April 28. The minister declared the outbreak of a new influenza following the World Health Organization's upgrading of its alert level.

Death toll from anticancer drug rises to over 100 in Japan

TOKYO, Japan - Nearly 500 people experienced debilitating side effects from an anticancer British-made drug called Iressa (in file photo), resulting in more than 100 deaths in Japan, the Ministry of Health, Labor and Welfare said Dec. 25. As of Dec. 13, of the 358 people who experienced side effects such as pneumonia and lung damage, 114 died, the ministry said.